s 58 55475 1236142800 false 1236229200 525 1592 111 300037

3/4/2009--Introduced.Pharmaceutical Market Access and Drug Safety Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States. Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use. Establishes registration conditions for importers and exporters. Requires the Secretary of Health and Human Services to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions. Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences. Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug. States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement. Requires the Secretary to educate consumers regarding prescription drug importation. Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA. Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.

1236229200 2009-03-05 Wed Jan 06 06:49:29 -0600 2010 introduced 55475 'act':7 '2009':9 'drug':5 'access':3 'market':2 'safeti':6 'pharmaceut':1 71592 false short introduced 55475 'act':11 'bill':2 'drug':8,19 'food':7 'amend':4 'feder':6 'cosmet':10 'import':16 'purpos':23 'respect':13 'prescript':18 69434 false official action 55475 1236229200 Thu Mar 05 00:00:00 -0600 2009 191159 Sponsor introductory remarks on measure. (CR S2780-2781) D000432 1942-05-14 9037 322 Hart Senate Office Building http://dorgan.senate.gov/contact/contact_form.cfm 202-224-1193 Byron 'd':4 'nd':5 'sen':1 'byron':2,6,8 'dorgan':3,7,9 M 300037 Dorgan Byron_Dorgan L. Sen. Byron Dorgan [D, ND] 5436 N00004615 9787 Democrat 202-224-2551 Lutheran ND Byron Dorgan 4.10714285714286 http://dorgan.senate.gov senatordorgan action 55475 1236229200 Thu Mar 05 00:00:00 -0600 2009 191159 Sponsor introductory remarks on measure. (CR S2780-2781) action 55475 1236142800 Wed Mar 04 00:00:00 -0600 2009 186066 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. introduced 55475 1236142800 Wed Mar 04 00:00:00 -0600 2009 186065